It is a pharma private limited company based in Ghevra, Delhi, India, established in 2009.
2009 | Ghevra, Delhi, India | ActiveIntaglio Biotech Private Limited, a active private limited company, was established on 09 October 2009 in Ghevra, Delhi, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24232DL2009PTC195092. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.60 M.
It upholds a compliant status. Its leadership includes Rizwan (Director), Salil Kumar (Director). Past directors included Ramesh Mehta, Rajesh Goyal, Sanjay Ahuja. It holds ₹1.05 M open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Plot No,-737/201, New Pole, Line,, Ghevra, Delhi, 110041.
U24232DL2009PTC195092
195092
09 October 2009
₹2.00 M
₹0.60 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Intaglio Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rizwan | Director | 13 Mar 2020 | Current |
| Salil Kumar | Director | 01 Jun 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2012 | Past |
| Pramod Abcsdd | Director | 01 Jul 2011 | Past |
| Pramod Abcsdd | Director | 13 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 24 Jul 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Intaglio Biotech Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 21.57% increase in profit. The company's net worth dipped by a decrease of 0.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Intaglio Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,050,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2011 | Punjab National Bank | ₹1.05 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Intaglio Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Intaglio Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intaglio Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rizwan was appointed as a Director was appointed as a Director on 13 Mar 2020 & has been associated with this company since 5 years 10 months . was documented.
Progress on Intaglio Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
Progress on Intaglio Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was documented.
Salil Kumar was appointed as a Director was appointed as a Director on 01 Jun 2012 & has been associated with this company since 13 years 7 months . was recorded as a recent event.
Progress on A charge with Punjab National Bank amounted to Rs. 1.05 M with Charge ID 10321042 was registered on 01 Nov 2011. was documented.
Progress on Intaglio Biotech Private Limited was registered on 09 Oct 2009 with Roc Delhi & aged 16 years 3 months as per MCA records. was documented.
The CIN of Intaglio Biotech Private Limited is U24232DL2009PTC195092.
Intaglio Biotech Private Limited is headquartered at Plot No,-737/201, New Pole, Line,, Ghevra, Delhi, 110041.
Intaglio Biotech Private Limited was incorporated on 09 October 2009.
The current directors of Intaglio Biotech Private Limited are
The primary industry of Intaglio Biotech Private Limited is Hospital And Medical Care.
Intaglio Biotech Private Limited is unlisted.
The authorized capital of Intaglio Biotech Private Limited is ₹2.00 M, and the paid-up capital is ₹0.60 M.
The compliance status of Intaglio Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX